 |
 |
 |
|
 |
|
 |
 |
 |
 |
 |
Inhaltsverzeichnis
|
| |||||||||||
|
| ||||||||||||
|
Inhaltsverzeichnis
|
||||||||||||
|
| Sie befinden sich hier: Inhaltsverzeichnis | ||
|
Medikamente Dies ist die Medikamenten-Datenbank der Medicle Organisation. | ||
| Medikamente | ||
|
1 Unsortiert - Medikamente | ||
|
1.1 Finasterid (Rudiment) | ||
|
1.5 Pyrazinamid (Rudiment) | ||
|
2 Herz-Kreislauf | ||
|
2.1 Sympathomimetika | ||
|
2.2 Sympatholytika | ||
|
2.2.1 Alpha-Adrenorezeptorenblocker | ||
|
2.2.2 Beta-Adrenorezeptorenblocker | ||
|
2.3 Parasympathomimetika | ||
|
2.4 Parasympatholytika | ||
|
2.5 Antihypertensiva | ||
|
2.5.1 Vasodilatoren | ||
|
2.5.1.3 Diazoxid | ||
|
2.5.1.4 Nitroprussid-Natrium | ||
|
2.5.2 Calciumkanalblocker | ||
|
2.5.2.1 Dihydropyridine (Rudiment) | ||
|
2.5.2.2 Verapamil | ||
|
2.5.2.3 Diltiazem (Rudiment) | ||
|
2.5.3 Antisympathotonika | ||
|
2.5.3.1 Reserpin | ||
|
2.5.3.2 Guanethidin | ||
|
2.5.3.3 α-Methyl-Dopa | ||
|
2.5.3.4 Clonidin | ||
|
2.5.3.5 Moxonidin (Rudiment) | ||
|
2.5.3.6 Urapidil (Rudiment) | ||
|
2.5.4 Konversionshemmer (ACE-Hemmer) | ||
|
2.5.5 Angiotensin-II-Rezeptor-Antagonisten | ||
|
2.6 Antiarrhythmika | ||
|
2.7 Herzglykoside | ||
|
2.8 Methylxanthine | ||
|
2.9 Organische Nitrate | ||
|
2.10 Volumenersatzmittel | ||
|
2.11 Anämietherapie | ||
|
2.12 Antikoagulation und Fibrinolytika | ||
|
2.12.1 Heparin (Rudiment) | ||
|
2.12.3 Thrombozytenhemmer | ||
|
2.12.3.1 Glykoprotein IIb/IIIa-Antagonisten | ||
|
3 Atmung | ||
|
4 Magen-Darm | ||
|
5 Wasser-, Elektrolyt-, Säure/Basenhaushalt | ||
|
6 Analgetika | ||
|
6.1 Nicht-steroidale Antirheumatika | ||
|
6.1.1 Aceclofenac | ||
|
7 Anästhesie | ||
|
8 Neurologie / Psychiatrie | ||
|
8.1 Hypnotika, Sedativa und Tranquillantien | ||
|
8.1.1 Barbiturate | ||
|
8.1.2 Benzodiazepine (Rudiment) | ||
|
8.1.3 Benzodiazepinrezeptor-Agonisten | ||
|
8.2 Antidepressiva | ||
|
8.2.1 Übersicht (Rudiment) | ||
|
8.2.2 Trizyklische Antidepressiva | ||
|
8.2.4 Pflanzliche Präparate | ||
|
8.3 Zentrale Muskelrelaxantien | ||
|
8.3.1 Baclofen | ||
|
8.3.2 Carisoprodol | ||
|
8.3.3 Tizanidin | ||
|
8.3.4 Memantin | ||
|
8.3.5 Tetrazepam (Rudiment) | ||
|
8.3.6 Tolperison | ||
|
9 Endokrinologie | ||
|
9.1 Orale Antidiabetika | ||
|
9.2 Vitamin-D-Stoffwechsel | ||
|
9.2.1 Cholecalciferol (Vitamin D3) | ||
|
9.2.2 Calcitriol (Rudiment) | ||
|
9.2.3 Calcipotriol (Rudiment) | ||
|
9.2.4 Tacalcitol | ||
|
10 Antibiotika | ||
|
10.1 β-Laktamantibiotika | ||
|
10.1.1 Penicilline | ||
|
10.1.2 Cephalosporine | ||
|
10.1.2.1 Übersicht | ||
|
10.1.2.3 Cefuroxim-Gruppe (2. Generation) | ||
|
10.1.2.4 Cefotaxim-Gruppe (3. Generation) | ||
|
10.2 Virostatika | ||
|
10.2.1 Medikamente gg. α-Herpesviren | ||
|
10.2.2 Medikamente gg. CMV-Viren | ||
|
10.2.2.1 Ganciclovir | ||
|
10.2.2.2 Foscarnet | ||
|
10.2.2.3 Cidofovir | ||
|
10.2.2.4 Fomivirsen | ||
|
10.2.3 Medikamente gg. Influenza-Viren | ||
|
10.2.3.1 Amantadin | ||
|
10.2.3.2 Zanamivir | ||
|
10.2.3.3 Oseltamivir | ||
|
10.3 Antimykotika | ||
|
10.3.1 Topische Therapie (Rudiment) | ||
|
10.3.2 Polyene | ||
|
10.3.2.1 Amphotericin B | ||
|
10.3.2.2 Nystatin | ||
|
10.3.3 Flucytosin | ||
|
10.3.4 Azole | ||
|
10.3.5 Sonstige | ||
|
10.3.5.1 Griseofulvin | ||
|
10.3.5.2 Terbinafin (Rudiment) | ||
|
10.3.5.3 Caspofungin | ||
|
10.3.5.4 Tolnaftat | ||
|
10.3.5.5 Amorolfin | ||
|
10.4 Lepramittel | ||
|
11 Zytostatika und Immunsuppressiva | ||
|
11.1 Zytostatika | ||
|
11.1.1 Schädigung der DNS | ||
|
11.1.1.1 Alkylantien | ||
|
11.1.1.1.1 Cyclophosphamid (Rudiment) | ||
|
11.1.1.2 Platinderivate | ||
|
11.1.1.3 Interkalierende Substanzen | ||
|
11.1.1.4 Topoisomerase-Hemmer | ||
|
11.1.2 Interferenz mit der DNS-Synthese | ||
|
11.1.2.1 DHFR-Hemmer | ||
|
11.1.2.2 RNR-Hemmer | ||
|
11.1.2.2.1 Hydroxyurea | ||
|
11.1.2.3 Purin-Antimetabolite | ||
|
11.1.2.4 Pyrimidin-Antimetabolite | ||
|
11.1.3 Interferenz mit Mikrotubuli | ||
|
11.2 Immunstimulantien | ||
|
11.3 Immunsuppressiva | ||
|
11.3.1 Glukokortikoide | ||
|
11.3.1.1 Topische Glukokortikoide (Rudiment) | ||
|
11.3.2 Antiproliferative Medikamente | ||
|
11.3.2.1 Azathioprin | ||
|
11.3.3 Calcineurin-Inhibitoren | ||
|
11.3.3.2 Tacrolimus | ||
|
11.3.4 TOR-Inhibitoren | ||
|
11.3.4.1 Sirolimus | ||
|
11.4 Neuere Verfahren | ||
|
11.4.2 Polyklonale Antikörper | ||
|
11.4.2.1 Antithymozyten-Immunoglobulin | ||
|
11.4.2.2 Antilymphozyten-Immunoglobulin | ||
|
11.4.3 Monoklonale Antikörper | ||
|
11.4.4 Übersicht Rezeptoren und Faktoren (Rudiment) | ||
| |||